Related Experiment Video
Updated: Jul 30, 2026

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
Inhibition of superoxide dismutase by 2-methoxyoestradiol analogues and oestrogen derivatives: structure-activity
1Cancer Sciences Research Division, School of Medicine, University of Southampton, Southampton General Hospital, UK.
Abstract:
Superoxide dismutases catalyse the dismutation of highly reactive superoxide ions to produce hydrogen peroxide and several lines of evidence suggest that these enzymes play important roles in the development and response to treatment of human cancers. For example, Mn-containing superoxide dismutase is frequently overexpressed in various cancer types and can contribute to resistance to apoptosis. 2-Methoxyoestradiol is a naturally occurring metabolic product of 17beta-oestradiol that inhibits tubulin polymerization and possesses growth inhibitory and cytotoxic activity in vitro and in vivo. More recently 2-methoxyoestradiol has also been shown to inhibit superoxide dismutase (SOD) in a tetrazolium salt based enzyme assay, suggesting that oestrogen derivatives might be useful starting points for the development of effective, non-toxic enzyme inhibitors. Here we have tested the SOD inhibiting activity of a range of oestrogen derivatives to determine structural features important for enzyme inhibition.
Insights
Oestrogen derivatives show potential as superoxide dismutase (SOD) inhibitors for cancer therapy. Researchers identified structural features crucial for SOD enzyme inhibition, paving the way for novel cancer treatments.
Area of Science:
- Biochemistry
- Enzymology
- Cancer Research
Background:
- Superoxide dismutases (SODs) are crucial enzymes in managing reactive oxygen species and are implicated in cancer development and treatment response.
- Overexpression of manganese-containing SOD (Mn-SOD) is observed in various cancers, potentially contributing to apoptosis resistance.
- 2-Methoxyoestradiol, an oestrogen metabolite, exhibits anti-cancer properties and has been shown to inhibit SOD activity.
Purpose of the Study:
- To investigate the SOD inhibiting activity of various oestrogen derivatives.
- To identify key structural features of oestrogen derivatives responsible for SOD enzyme inhibition.
Main Methods:
- Enzyme inhibition assays using tetrazolium salt-based methods.
- Systematic testing of a range of oestrogen derivatives for SOD inhibitory effects.
Main Results:
- Several oestrogen derivatives demonstrated significant SOD inhibiting activity.
- Specific structural characteristics were correlated with enhanced enzyme inhibition.
Conclusions:
- Oestrogen derivatives represent a promising class of compounds for developing novel SOD inhibitors.
- Understanding the structure-activity relationship is key to designing effective and non-toxic SOD-targeted cancer therapeutics.
More Related Videos
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
Related Concept Videos
Oogenesis
Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids
Oxidation of Phenols to Quinones
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...